Sicagen India Board of Directors

Get the latest insights into the leadership at Sicagen India. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Ashwin C Muthiah Chairman
Mr. Nandakumar Varma Whole Time Director
Mr. R Chandrasekar Director
Mr. Devaki Ashwin Muthiah Director
Ms. Govindarajan Dattatreyan Sharma Independent Director
Ms. Rita Chandrasekar Independent Director
Mr. S Radhakrishnan Independent Director
Mr. Batchu Sai Purshotham Independent Director

Sicagen India Share price

SICAGEN

76.4

1.37 (1.83%)
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

76.75

Today's Low

74.07

52 Week Low

54.00

52 Week High

118.80

The current prices are delayed, login to your account for live prices

Sicagen India FAQs

The board at Sicagen India consists of experienced professionals, including Mr. Ashwin C Muthiah , Mr. Nandakumar Varma , and others, overseeing the company’s strategic and corporate governance.

Directors at Sicagen India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Ashwin C Muthiah is the current chairman at Sicagen India.

Executive directors at Sicagen India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Sicagen India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Sicagen India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.